Target Name: MCF2L
NCBI ID: G23263
Review Report on MCF2L Target / Biomarker Content of Review Report on MCF2L Target / Biomarker
MCF2L
Other Name(s): Guanine nucleotide exchange factor DBS (isoform c) | KIAA0362 | MCF.2 cell line derived transforming sequence like, transcript variant 2 | Guanine nucleotide exchange factor DBS (isoform d) | MCF2L va

Understanding The Potential of DBS as A Drug Target Or Biomarker

Guanine nucleotide exchange factor DBS (isoform c) is a protein that plays a critical role in the regulation of protein-protein interactions, specifically in the process of protein-protein folding. It is a protein that is expressed in most tissues and cells and is involved in the formation of many different proteins. Despite its importance, little is known about DBS and its potential as a drug target or biomarker. In this article, we will explore the biology of DBS, its potential drug target potential, and its potential as a biomarker for various diseases.

The Biology of DBS
DBS is a protein that is composed of 21 amino acid residues and has a calculated molecular weight of 19.1 kDa. It is a member of the nucleotide transport protein family and is expressed in most tissues and cells. DBS is involved in the regulation of protein-protein interactions and in the formation of many different proteins.

One of the key functions of DBS is its role in the regulation of protein-protein interactions. DBS is a protein that plays a critical role in the formation of the interface between two proteins. This interface is known as a protein-protein domain and is the site where the two proteins meet and interact with each other.

DBS is also involved in the regulation of protein-protein interactions by influencing the formation of a disulfide bond. A disulfide bond is a covalent bond that forms between two amino acids when they come together. DBS helps to regulate the formation of these bonds by interacting with the amino acids that are involved in the formation of the bond.

In addition to its role in protein-protein interactions, DBS is also involved in the regulation of protein-protein interactions by influencing the stability of protein structures. Proteins have a unique structure that is determined by the sequence of their amino acids. The structure of a protein determines its function and the stability of its structure is important for its function. DBS is involved in the regulation of the stability of protein structures by interacting with the amino acids that are involved in the formation of the structure.

Potential Drug Target
DBS has the potential to be a drug target due to its involvement in the regulation of protein-protein interactions. Many drugs work by binding to specific protein-protein domains or by modulating the stability of protein structures. DBS is involved in the regulation of both protein-protein interactions and protein-protein stability, which makes it an attractive target for drugs that are designed to modulate these processes.

In addition to its potential as a drug target, DBS also has the potential as a biomarker for various diseases. The regulation of protein-protein interactions is involved in many different diseases, including cancer, neurodegenerative diseases, and diseases that are caused by protein misfolding. DBS may be a useful biomarker for these diseases because it is involved in the regulation of the processes that are altered in these diseases.

Potential Biomarker
DBS has the potential as a biomarker for various diseases because it is involved in the regulation of protein-protein interactions. Many diseases are caused by changes in the structure and function of proteins, including those that are involved in cancer, neurodegenerative diseases, and diseases caused by protein misfolding. DBS may be a useful biomarker for these diseases because it is involved in the regulation of the processes that are altered in these diseases.

Conclusion
In conclusion, DBS is a protein that is involved in the regulation of protein-protein interactions and has the potential to be a drug target or biomarker. Its role in the regulation of protein-protein interactions makes it an attractive target for drugs that are designed to modulate these processes. In addition, DBS may be a useful biomarker for various diseases because it is involved in the regulation of the processes that are altered in these diseases. Further research is needed to fully understand the role of DBS in protein-protein interactions and its potential as a drug target

Protein Name: MCF.2 Cell Line Derived Transforming Sequence Like

Functions: Guanine nucleotide exchange factor that catalyzes guanine nucleotide exchange on RHOA and CDC42, and thereby contributes to the regulation of RHOA and CDC42 signaling pathways (By similarity). Seems to lack activity with RAC1. Becomes activated and highly tumorigenic by truncation of the N-terminus (By similarity). Isoform 5 activates CDC42 (PubMed:15157669)

The "MCF2L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MCF2L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MCF2L-AS1 | MCF2L2 | MCFD2 | MCFD2P1 | MCHR1 | MCHR2 | MCHR2-AS1 | MCIDAS | MCL1 | MCM10 | MCM2 | MCM3 | MCM3AP | MCM3AP-AS1 | MCM4 | MCM5 | MCM6 | MCM7 | MCM8 | MCM8-MCM9 complex | MCM9 | MCMBP | MCMDC2 | MCOLN1 | MCOLN2 | MCOLN3 | MCPH1 | MCPH1-AS1 | MCPH1-DT | MCRIP1 | MCRIP2 | MCRS1 | MCTP1 | MCTP2 | MCTS1 | MCTS2 | MCU | MCUB | MCUR1 | MDC1 | MDFI | MDFIC | MDGA1 | MDGA2 | MDH1 | MDH1B | MDH2 | MDK | MDM1 | MDM2 | MDM4 | MDN1 | MDS2 | ME1 | ME2 | ME3 | MEA1 | MEAF6 | MEAF6P1 | MEAK7 | Mechanoelectrical transducer (MET) channel | Mechanosensitive Ion Channel | MECOM | MECOM-AS1 | MeCP1 histone deacetylase (HDAC) complex | MECP2 | MECR | MED1 | MED10 | MED11 | MED12 | MED12L | MED13 | MED13L | MED14 | MED14P1 | MED15 | MED15P8 | MED16 | MED17 | MED18 | MED19 | MED20 | MED21 | MED22 | MED23 | MED24 | MED25 | MED26 | MED27 | MED28 | MED29 | MED30 | MED31 | MED4 | MED4-AS1 | MED6 | MED7 | MED8 | MED9